European training network for development of personalized anti-infective medical devices combining printing technologies and antimicrobial functionality

DOCTORAL STUDENT (ESR1) for ‘Identification, mechanistic characterization and chemical optimization of repurposed anti-biofilms’ in H2020 Marie Sklodowska-Curie ETN PRINT-AID

The University of Helsinki – among the best in the world

Founded in 1640, the University of Helsinki is one of the best multidisciplinary research universities in the world. The University of Helsinki is an international academic community of 40,000 students and staff members. It operates on four campuses in Helsinki and at 15 other locations. The high-quality research carried out by the university creates new knowledge for educating diverse specialists in various fields, and for utilization in social decision-making and the business sector.

The Faculty of Pharmacy (http://www.helsinki.fi/pharmacy) is located on the Viikki campus and offers Bachelor's, Master's and postgraduate programs. The Faculty also provides professional postgraduate education in industrial pharmacy for those with a Bachelor or Master's degree in pharmacy and plays an active part in the continuing education in the field.

The Faculty of Pharmacy invites applications for a

DOCTORAL STUDENT / EARLY STAGE RESEARCHER (ESR1) POSITION in Horizon2020 MSCA European Training Network ‘PRINT-AID: Development of personalized anti-infective medical devices combining printing technologies and antimicrobial functionality

The position is for three years (36 months) starting in June 2017 or as agreed. There will be a four-month trial period, during which the PhD study right is to be applied for and got.

Doctoral training will be carried out at Professor Pia Vuorela’s multi-disciplinary research group at the University of Helsinki. The Research group (https://www.helsinki.fi/en/researchgroups/exploration-of-anti-infectives) offers a training in the field of anti-infective drug discovery. The biofilm team of the group targets bacterial biofilms and has several well-established methods for testing compounds for anti-biofilm activity in vitro.

The successful candidate will identify promising anti-biofilm leads which originate from currently existing investigational or approved drugs, investigate their mode of actions on bacterial biofilms as well as perform structural optimizations that will benefit the inclusion of these drugs into 3D-printable formulations to be used in medical devices. The focus of this project will be on repurposed drugs. The doctoral training includes an inter-sectoral secondment to Aptuit (http://www.aptuit.com) Verona, Italy for learning and performing structural optimizations and mode-of-action studies of the selected repurposed molecules.

Requirements for the position are

  • MSc degree in an appropriate field of life sciences (e.g. pharmacy, medicine, chemistry, biology).
  • Knowledge of early drug discovery or knowledge of bacterial biofilms and prior experience in either of these topics will be considered a benefit
  • Strong motivation in pursuing doctoral studies
  • Readiness to work in a highly multi-disciplinary research environment
  • Fulfillment of H2020 MSCA eligibility criteria for the position (see below)

H2020 MSCA eligibility criteria

Applicants shall, at the time of recruitment by the host organization, be in the first four years of their research careers and not yet have been awarded a doctoral degree. Full-time equivalent research experience is measured from the date when a researcher obtained the degree that would formally entitle him/her to embark on a doctorate.

H2020 MSCA Mobility Rule: at the time of recruitment by the host organization, researchers must not have resided or carried out their main activity (work, studies, etc.) in the country of their host organization (Finland) for more than 12 months in the 3 years immediately prior to the recruitment date. Compulsory national service and/or short stays such as holidays are not taken into account.

Please note that during the recruitment process you are asked to provide documents to prove your eligibility (status of Early Stage Researcher and fulfillment of Mobility rule) for the position.

We offer salary for three years based on H2020 MSCA ETN programme, consisting of Living and Mobility allowances. The candidates may also qualify for Family allowance depending of their family status. All standard pension benefits and occupational health care are provided for university employees.

To apply, please submit your application with attachments by March 15th 2017 using the University of Helsinki electronic recruitment system (the Apply link provided below). 

In your application, please include

  • CV (with possible publications included),
  • Copy of university MSc diploma including your completed courses during the M.Sc
  • Contact details of two references (e.g. M.Sc. thesis supervisors)
  • Motivation letter (max 1 page) with a description of your researcher interests and explanation why you would be a suitable candidate for the project. In case you apply to several PRINT-AID ESR positions indicate you rank in the motivation letter.

For more information on the position, please contact Postdoctoral Researcher Malena Skogman: This email address is being protected from spambots. You need JavaScript enabled to view it..

APPLY LINK

APPLICATION DEADLINE 15th March 2017